April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Dhea-Analogue Neuroprotection In An Experimental Model Of Retinal Detachment
Author Affiliations & Notes
  • Pavlina A. Tsoka
    Neurology & Sense Organs,
    University of Crete, Heraklion, Crete, Greece
  • Ioannis Charalampopoulos
    Pharmacology,
    University of Crete, Heraklion, Crete, Greece
  • Achilleas Gravanis
    Pharmacology,
    University of Crete, Heraklion, Crete, Greece
  • Miltiadis K. Tsilimbaris
    Neurology & Sense Organs,
    University of Crete, Heraklion, Crete, Greece
  • Footnotes
    Commercial Relationships  Pavlina A. Tsoka, None; Ioannis Charalampopoulos, None; Achilleas Gravanis, None; Miltiadis K. Tsilimbaris, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5443. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pavlina A. Tsoka, Ioannis Charalampopoulos, Achilleas Gravanis, Miltiadis K. Tsilimbaris; Dhea-Analogue Neuroprotection In An Experimental Model Of Retinal Detachment. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5443.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the neuroprotective activity of a new synthetic analogue of Dehydroepiandrosterone (DHEA) in an experimental model of retinal detachment (RD).

Methods: : Sprague Dawley rats underwent a retinal detachment in their right eye under deep anesthesia while the left eye was served as a control. Animals were dived into three groups and injected with the synthetic DHEA analogue. The analogue can be detected in the rat retina after intraperitoneal injection. Animals received intraperitoneally 10 mg of the analogue diluted in 70 ul of ethanol in a total volume of 1 ml WFI per animal. In the first group the injections were administered after RD while in the other two groups (group 2 and 3) a pretreatment was utilized starting 7 days before RD (every day and every second day, respectively). The animals were sacrificed three days after RD, the eyes were enucleated and prepared for TUNEL labeling and confocal microscopy.

Results: : Morphological analysis revealed that the phenotype is rescued when the administration of the analogue begins before retinal detachment, with only a few cells labeled positive after TUNEL staining in groups 2 and 3. Administration of the drug only after the retinal detachment (group 1) seemed to have less anti-apoptotic effect.

Conclusions: : Our results suggest that this molecule may prove to be anti-apoptotic in retinal detachment induced apoptosis. Further investigation is required for the most efficient treatment and drug dosage in several time points of the apoptotic process.

Keywords: retinal detachment • apoptosis/cell death • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×